Financhill
Back

Axsome Therapeutics Stock Price Chart

  • The current trend is moderately bullish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.

Axsome Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 111.22 Buy
20-day SMA: 106.93 Buy
50-day SMA: 106.84 Buy
200-day SMA: 103.6 Buy
8-day EMA: 110.61 Buy
20-day EMA: 108.53 Buy
50-day EMA: 107.74 Buy
200-day EMA: 103.1 Buy

Axsome Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.64 Buy
Relative Strength Index (14 RSI): 58.82 Buy
Chaikin Money Flow: -268888 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (102.33 - 110.09) Buy
Bollinger Bands (100): (102.09 - 119.75) Buy

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Axsome Therapeutics Stock

Is Axsome Therapeutics Stock a Buy?

AXSM Technical Analysis vs Fundamental Analysis

Sell
40
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy or a Sell?

Axsome Therapeutics Stock Info

Market Cap:
5.5B
Price in USD:
111.70
Share Volume:
453.7K

Axsome Therapeutics 52-Week Range

52-Week High:
139.13
52-Week Low:
72.21
Sell
40
Axsome Therapeutics (AXSM) is a Sell

Axsome Therapeutics Share Price Forecast

Is Axsome Therapeutics Stock a Buy?

  • Axsome Therapeutics share price is 111.70 while AXSM 8-day exponential moving average is 110.61, which is a Buy signal.
  • The stock price of AXSM is 111.70 while Axsome Therapeutics 20-day EMA is 108.53, which makes it a Buy.
  • Axsome Therapeutics 50-day exponential moving average is 107.74 while AXSM share price is 111.70, making it a Buy technically.
  • AXSM stock price is 111.70 and Axsome Therapeutics 200-day simple moving average is 103.10, creating a Buy signal.

Fundamental Analysis of Axsome Therapeutics

Is Axsome Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.56 per share, an increase next quarter of $0.93 per share, an increase this year of $1.62 per share, and an increase next year of $5.02 per share.

Technical Analysis of Axsome Therapeutics

Should I short Axsome Therapeutics stock?

* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.